Skip to content

A Study to compare the effect of two doses of Dexmeditomedine used as an adjuvant to lignocaine for infiltration block done for tympanoplasty.

A study to compare two different doses of Dexmeditomedine (0.5mcg/Kg Vs 1 mcg/Kg) as an adjuvant to 2% Lignocaine infiltration block for tympanoplasty, a randomized control trail. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057450
Enrollment
90
Registered
2023-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H663- Other chronic suppurative otitis media Health Condition 2: H679- Otitis media in diseases classified elsewhere, unspecified ear

Interventions

Intervention1: lower dose of Dexmeditomedine: Dexmedetomidine (0.5mcg/kg) as an adjuvant to 2% lignocaine in infiltration block for Tympanoplasty. patients will be Observed for first 24

Sponsors

Indira Gandhi institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients scheduled for Tympanoplasty >18yrs to b)American Society of Anesthesiologists (ASA) physical status I to II

Exclusion criteria

Exclusion criteria: a)Patient refusal b)Patients with severe cardiopulmonary diseases c)Patients allergic to local anesthetics d) Inability to communicate and cooperate e) Infection at surgical site-

Design outcomes

Primary

MeasureTime frame
To compare the intra-operative bleeding at surgical siteTimepoint: every ten minutes during surgical procedure

Secondary

MeasureTime frame
1. Time of first analgesia requirement 2.degree of sedation 3.surgeons’ satisfaction 4.intraoperative hemodynamics Timepoint: every ten minutes intraoperatively ,then four hourly upto 24 hours post operatively

Countries

India

Contacts

Public ContactRicha Singh

Indira Gandhi institute of medical sciences, Patna

anucdry@gmail.com7385161632

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026